<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-3K81XY9R</identifier><date>2015</date><creator>Gregorič Kumperščak, Hojka</creator><relation>documents/doc/3/URN_NBN_SI_doc-3K81XY9R_001.pdf</relation><relation>documents/doc/3/URN_NBN_SI_doc-3K81XY9R_001.txt</relation><format format_type="issue">2</format><format format_type="volume">66</format><format format_type="type">article</format><format format_type="extent">str. 185-189</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">5364543</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-3K81XY9R</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">droge</subject><subject language_type_id="slv">kanabis</subject><subject language_type_id="slv">mladostniki</subject><subject language_type_id="slv">psihoze</subject><subject language_type_id="slv">shizofrenija</subject><title>Psihotične motnje v adolescenci in njihova povezava z uživanjem prepovedanih drog</title><title>Psychotic disorders in adolescence and association with use of psychoactive substances</title></Record>